Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Celestino Rodríguez,1 Trinidad García,1 Débora Areces,1,2 Estrella Fernández,1 Marcelino García-Noriega,3 Joan Carles Domingo41Department of Psychology, Faculty of Psychology, University of Oviedo, Oviedo, Spain; 2Child Education Program, Facult...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rodríguez C, García T, Areces D, Fernández E, García-Noriega M, Domingo JC
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Omega 3
PUFAs
Eicosapentaenoic Acid (EPA)
docosahexaenoic acid (DHA)
Attention Deficit Hyperactivity Disorder (ADHD)
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/708e34b9af7940a7b045ab3b4c50a0cd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/708e34b9af7940a7b045ab3b4c50a0cd

Ejemplares similares